20th September 2019 by Louise Hudman
This is a new guideline from NICE giving advice on ertugliflozin, published in April 2019. I am also doing a quick reminder about the other SGLT-2 inhibitors.
It is another sodium-glucose co-transporter 2 (SGLT-2) inhibitor, like canagliflozin, dapagliflozin and empagliflozin.
It is thought to be as effective as the other SGLT-2 inhibitors, but it is cheaper.
e-learning | Sotagliflozin with insulin for type 1 diabetes
A new guideline from NICE from February 2020 advises that sotagliflozin can be used alongside insulin for type 1 diabetes
Dapagliflozin with insulin for patients with Type 1 Diabetes
This is a new guideline from NICE on using dapagliflozin in patients with Type 1 diabetes.
e-learning | Ertugliflozin in type 2 diabetes and the other SGLT-2 inhibitors
This is a new guideline from NICE giving advice on ertugliflozin, published in April 2019. I am also doing a quick reminder about the other SGLT-2 inhibitors.
"I don’t normally do this, but just to say that I thought your article at the front of the latest NASGP magazine about clinical errors was really excellent. Great, and very thoughtful writing. NASGP member."
‘Great, and very thoughtful writing’
